We narrowed to 19,475 results for: gateway
-
Plasmid#118375PurposeExpression vector for BioID in mammalian system. Gateway compatible destination vector to generate stable, inducible cell line expressing N-terminally tagged HABirA* and protein of interest.DepositorTypeEmpty backboneUseDestinationTagsHA-BirA*ExpressionMammalianAvailable sinceNov. 30, 2018AvailabilityAcademic Institutions and Nonprofits only
-
pDONR223-H-RAS V12
Plasmid#31201PurposeGateway donor vector containing HRAS G12V.DepositorAvailable sinceJuly 12, 2011AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pDestattB_ubi:EGFP (pCM272)
Plasmid#68339PurposeMultisite Gateway destination vector for phiC31-mediated transgenesis in zebrafish, harbors ubiquitin promoter (ubi)-driven EGFP.DepositorInsertEGFP
UseZebrafish transgenesisPromoterubiAvailable sinceAug. 13, 2015AvailabilityAcademic Institutions and Nonprofits onlyCited by -
Hygro-iDEST
Plasmid#75339PurposeGATEWAY destination vector for site-specific integration into the human AAVS1/PPP1R12C locus for doxycycline-inducible gene over-expressionDepositorInsertTRE-DEST
ExpressionMammalianPromoterTRE-tightAvailable sinceMay 24, 2016AvailabilityAcademic Institutions and Nonprofits onlyCited by -
p3E-APEX2-P2A-mKate2
Plasmid#67671PurposeMultisite gateway entry clone for adding C-terminal fusions of APEX2-P2A-mKate2DepositorInsertAPEX2-P2A-mKate2
UseGateway multisite 3' entry cloneAvailable sinceNov. 30, 2015AvailabilityAcademic Institutions and Nonprofits only -
pDONR221_SLC1A5
Plasmid#131974PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC1A5 (SLC1A5 Human)
ExpressionMammalianAvailable sinceOct. 18, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR223 SARS-CoV-2 NSP2
Plasmid#141256PurposeGateway-compatible Entry vector, with insert of NSP2 gene's CDS from SARS-CoV-2 isolate Wuhan-Hu-1DepositorInsertNSP2 (ORF1ab SARS-CoV-2 isolate Wuhan-Hu-1)
UseGateway CloningMutationMany synonymous changes due to codon optimizationAvailable sinceMay 6, 2020AvailabilityIndustry, Academic Institutions, and Nonprofits -
pMuLE Lenti Dest Neo
Plasmid#62178PurposeMuLE (Multiple Lentiviral Expression) Destination vector for use with pMuLE Entry vectors. Co-expresses Neomycin cassette under the control of a PGK promoter. Compatible with MultiSite Gateway cloningDepositorTypeEmpty backboneUseLentiviral; Mule gateway destination vectorExpressionMammalianAvailable sinceJune 16, 2015AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pMSCVpuro-DEST
Plasmid#119745PurposeAllows Gateway cloning of gene of interest into retroviral pMSCV vector (with Puromycin resistance)DepositorTypeEmpty backboneUseRetroviralExpressionMammalianAvailable sinceFeb. 6, 2019AvailabilityAcademic Institutions and Nonprofits onlyCited by -
Target Accelerator Pan-Cancer Mutant Collection
Plasmid kit#1000000103PurposeGateway entry vectors containing wildtype and mutant alleles found across cancer types for "pan-cancer" analyses.DepositorApplicationGene Expression and LabelingVector typeMammalian ExpressionAvailable sinceApril 24, 2017AvailabilityAcademic Institutions and Nonprofits only -
pMuLE Lenti Dest eGFP
Plasmid#62175PurposeMuLE (Multiple Lentiviral Expression) Destination vector for use with pMuLE Entry vectors. Co-expresses EGFP under the control of a PGK promoter. Compatible with MultiSite Gateway cloningDepositorTypeEmpty backboneUseLentiviral; Mule gateway destination vectorExpressionMammalianAvailable sinceJune 16, 2015AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pMuLE Lenti Dest iRFP
Plasmid#62176PurposeMuLE (Multiple Lentiviral Expression) Destination vector for use with pMuLE Entry vectors. Co-expresses iRFP under the control of a PGK promoter. Compatible with MultiSite Gateway cloningDepositorTypeEmpty backboneUseLentiviral; Mule gateway destination vectorExpressionMammalianAvailable sinceJune 16, 2015AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pDONR223_PIK3CA_p.E545K
Plasmid#82881PurposeGateway Donor vector containing PIK3CA, part of the Target Accelerator Plasmid Collection.DepositorAvailable sinceApril 24, 2017AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pLenti Dest BlastR R1-R2
Plasmid#84574PurposeGateway destination vector expressing Blasticidin resistance under a PGK promoterDepositorTypeEmpty backboneUseGateway Cloning and LentiviralExpressionMammalianPromoterPGKAvailable sinceJan. 5, 2017AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pDestattB/CY (pCM327)
Plasmid#68341PurposeMultisite Gateway destination vector to create transgenes for phiC31-mediated transgenesis in zebrafish, contains an attB site and alpha-cystallin:YFP (CY) transgenesis marker in backbone.DepositorTypeEmpty backboneUseZebrafish transgenesisAvailable sinceAug. 20, 2015AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pDONR223_MYC_WT
Plasmid#82927PurposeGateway Donor vector containing MYC, part of the Target Accelerator Plasmid Collection.DepositorAvailable sinceApril 24, 2017AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pDONR221_SLC7A11
Plasmid#132244PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC7A11 (SLC7A11 Human)
ExpressionMammalianAvailable sinceNov. 21, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by -
pDONR223_EGFR_p.L858R
Plasmid#82906PurposeGateway Donor vector containing EGFR, part of the Target Accelerator Plasmid Collection.DepositorAvailable sinceApril 24, 2017AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pDONR223_STAT3_WT
Plasmid#82235PurposeGateway Donor vector containing STAT3, part of the Target Accelerator Plasmid Collection.DepositorAvailable sinceApril 24, 2017AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pDONR221_SLC2A1
Plasmid#132103PurposeGateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectorsDepositorInsertSLC2A1 (SLC2A1 Human)
ExpressionMammalianAvailable sinceDec. 3, 2019AvailabilityIndustry, Academic Institutions, and NonprofitsCited by